# Personalized Indications for CBT and Antidepressants in Treating Depression

> **NCT02752542** · PHASE4 · RECRUITING · sponsor: **Nova Scotia Health Authority** · enrollment: 80 (estimated)

## Conditions studied

- Major Depressive Disorder
- Persistent Depressive Disorder

## Interventions

- **BEHAVIORAL:** Cognitive Behavioral Therapy
- **DRUG:** Pharmacotherapy

## Key facts

- **NCT ID:** NCT02752542
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-10-31
- **Primary completion:** 2026-06
- **Final completion:** 2027-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02752542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02752542, "Personalized Indications for CBT and Antidepressants in Treating Depression". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT02752542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*